What drove the AVE.AX stock spike after hours on 05 Mar 2026?

The jump to A$0.012 was driven by heavy volume of 17,400,386 shares and short-term buying interest. There was no single public catalyst; market data and peer screens showed increased quote activity.

How does Meyka AI view AVE.AX stock?

Meyka AI rates AVE.AX with a score out of 100 at 64.17 (Grade B, HOLD). The grade balances momentum with weak cash flow and high valuation multiples. This is informational, not advice.

What are realistic price targets for AVE.AX stock?

Near-term resistance is around A$0.015, immediate support A$0.009. Meyka AI's 12-month forecast is A$0.01256, with multi-year scenarios of A$0.02076 (3 years) and A$0.02891 (5 years).

Should traders buy AVE.AX stock after the after-hours move?

Traders should watch for follow-through in regular hours and rising volume. The stock is volatile and fundamentals remain weak, so use tight risk controls and small position sizes.

AU Stocks

Avecho (AVE.AX) up to A$0.012 +33% after hours ASX 05 Mar 2026: watch volume

ByDanny Kontos March 5, 2026March 5, 2026

AVE.AX stock jumped to A$0.012, a 33.33% intraday rise, in after-hours trading on 05 Mar 2026. The move came on heavy volume of 17,400,386 shares and pushed price above the 50-day average of A$0.0096. This sudden gain reflects short-term buying interest in Avecho Biotechnology Limited (AVE.AX) on the ASX and sets a clear near-term test for support at A$0.009. We review causes, technicals, valuation, and Meyka AI’s forecast to frame trade and investment considerations for Australian investors.